NCT04032327View on ClinicalTrials.gov

Local Anesthetics on Postsurgical Analgesia Following Posterior Colporrhaphy

PHASE2CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

July 1, 2018

Primary Completion Date

August 25, 2020

Study Completion Date

August 25, 2020

Conditions
Postoperative Pain
Interventions
DRUG

Exparel plus plain bupivacaine

10 mL of extended release liposomal bupivacaine (Exparel) plus 10 mL of 0.25% plain bupivacaine mixed to be injected vaginally prior to the start of posterior colporrhaphy

DRUG

Bupivacaine

20 mL of 0.25% plain bupivacaine to be injected vaginally prior to the start of posterior colporrhaphy

Trial Locations (1)

20889

Walter Reed National Military Medical Center (WRNMMC), Bethesda

All Listed Sponsors
lead

Walter Reed National Military Medical Center

FED

NCT04032327 - Local Anesthetics on Postsurgical Analgesia Following Posterior Colporrhaphy | Biotech Hunter | Biotech Hunter